Cancer Moonshot Biobank - Biospecimen Source Site Coordinator (BSSC)

Solicitation Number: 
S18-087
Brief Description: 
The BSSC will a) enter into agreements with medical institutions (sites) to enroll research participants and collect biospecimens, b) provide study activation, training, coordination, and assistance, c) provide reimbursement for biospecimen acquisition, data acquisition, and participant and provider engagement activity, and d) invoice Leidos Biomed for those activities. Sites will primarily be members of the NCI National Community Oncology Research Program (NCORP). The project will utilize five or more sites in 2019, up to 55 in 2020, and adding up to 100 sites in 2021, depending on 1) patient recruitment, 2) sample submission, and 3) contractual and programmatic discussions with NCI. Leidos Biomed expects up to 150 sites may be engaged in total for the Biobank project.
Vendor Name: 
Leidos Biomedical Research, Inc.
POC Name: 
Mrs. Carol Caballero
Proposal Due Date: 
Friday, July 12, 2019
Research Category: 
Research & Development Services & Subcontracts
NAICS Codes: 
541990
NCI OA Contract Number: 
HHSN261201500003I - IDIQ
Proposal Instructions: 
Questions are due on 6/14/19. A bidder's Telecon will occur on 6/20/19 at 3 pm ET. The proposal is due at 2 pm ET on 7/12/19. Please contact Carol Caballero for a copy of the solicitation.

Solicitation Updates

Section Modified: Brief Description
Modified By: caballerocs
Change Date: 06/07/2019 - 11:49
Original Content: The BSSC will a) enter into agreements with each BSS or Alliance Biobank, b) provide study activation, training, coordination, and assistance, c) provide reimbursement to the BSSs for biospecimen acquisition, data acquisition, and Biobank-specific PPE activity, and d) invoice Leidos Biomed for those activities, including engagement. Biobank project will start with ~5 BSS in FY2019. In FY2020, the Biobank project may add 5 Alliance Biobanks and up to 45 additional BSSs. Leidos Biomed may potentially add 100 more BSSs in FY2021 depending on 1) patient recruitment, 2) sample submission, and 3) contractual and programmatic discussions with NCI. Leidos Biomed expects up to 150 BSS and/or up to 5 Alliance Biobanks may be engaged in total for the Biobank project.
Updated Content: The BSSC will a) enter into agreements with medical institutions (sites) to enroll research participants and collect biospecimens, b) provide study activation, training, coordination, and assistance, c) provide reimbursement for biospecimen acquisition, data acquisition, and participant and provider engagement activity, and d) invoice Leidos Biomed for those activities. Sites will primarily be members of the NCI National Community Oncology Research Program (NCORP). The project will utilize five or more sites in 2019, up to 55 in 2020, and adding up to 100 sites in 2021, depending on 1) patient recruitment, 2) sample submission, and 3) contractual and programmatic discussions with NCI. Leidos Biomed expects up to 150 sites may be engaged in total for the Biobank project.